| Literature DB >> 26968526 |
Benjamin Weixler1, Rene Warschkow2,3, Michaela Ramser1, Raoul Droeser1, Urs von Holzen1,4, Daniel Oertli1, Christoph Kettelhack5.
Abstract
BACKGROUND: It remains a matter of debate whether colorectal cancer resection in an emergency setting negatively impacts on survival. Our objective was therefore to assess the impact of urgent versus elective operation on overall and disease-free survival in patients undergoing resection for colorectal cancer by using propensity score adjusted analysis.Entities:
Keywords: Colorectal cancer; Disease-free survival; Emergency surgery; Oncological outcome; Overal survival
Mesh:
Year: 2016 PMID: 26968526 PMCID: PMC4787247 DOI: 10.1186/s12885-016-2239-8
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Patient characteristics and bias for urgent versus elective operation
| Patient characteristics in univariate analysis | Bias in multivariable logistic regression | Patient characteristics after propensity score matching | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total | Urgent | Elective |
| OR (95 % CI) |
| Urgent | Elective |
| ||
| Age | years | 71.4 ± 12.1 | 72.0 ± 11.2 | 71.3 ± 12.2 | 0.884a | 1.01 (0.99–1.03) | 0.490 | 72.1 ± 11.3 | 72.5 ± 11.7 | 0.760a |
| Sex | m | 421 (56.4 %) | 43 (51.2 %) | 378(57.0 %) | 0.311b | Reference | 0.517 | 42 (50.6 %) | 333.5 (53.7 %) | 0.594b |
| w | 326 (43.6 %) | 41 (48.8 %) | 285 (43.0 %) | 1.19 (0.71–1.99) | 41 (49.4 %) | 287.5 (46.3 %) | ||||
| Tumor localisation | Cecum | 132 (17.7 %) | 12 (14.3 %) | 120 (18.1 %) | 0.019b | Reference | 0.092 | 12 (14.5 %) | 95.4 (15.4 %) | 0.927b |
| Ascending colon | 130 (17.4 %) | 12 (14.3 %) | 118 (17.8 %) | 1.25 (0.50–3.19) | 12 (14.5 %) | 82.4 (13.3 %) | ||||
| Transverse colon | 40 (5.4 %) | 7 (8.3 %) | 33 (5.0 %) | 2.50 (0.80–7.43) | 7 (8.4 %) | 55.7 (9.0 %) | ||||
| Descending colon | 81 (10.8 %) | 12 (14.3 %) | 69 (10.4 %) | 2.29 (0.88–6.01) | 12 (14.5 %) | 80.9 (13.0 %) | ||||
| Sigmoid colon | 201 (26.9 %) | 32 (38.1 %) | 169 (25.5 %) | 1.95 (0.90–4.44) | 31 (37.3 %) | 258.1 (41.6 %) | ||||
| Rectum | 163 (21.8 %) | 9 (10.7 %) | 154 (23.2 %) | 0.78 (0.28–2.12) | 9 (10.8 %) | 48.7 (7.8 %) | ||||
| Perforation | No | 674 (90.2 %) | 56 (66.7 %) | 618 (93.2 %) | <0.001b | Reference | <0.001 | 56 (67.5 %) | 465.5 (75.0 %) | 0.144b |
| Yes | 73 (9.8 %) | 28 (33.3 %) | 45 (6.8 %) | 7.17 (3.93–13.09) | 27 (32.5 %) | 155.5 (25.0 %) | ||||
| Protective colostomy | No | 657 (88.0 %) | 71 (84.5 %) | 586 (88.4 %) | 0.306b | Reference | 0.129 | 70 (84.3 %) | 512.7 (82.6 %) | 0.687b |
| Yes | 90 (12.0 %) | 13 (15.5 %) | 77 (11.6 %) | 1.82 (0.83–3.80) | 13 (15.7 %) | 108.3 (17.4 %) | ||||
| Resection status | R0 | 718 (96.1 %) | 76 (90.5 %) | 642 (96.8 %) | 0.014c | Reference | 0.114 | 76 (91.6 %) | 571.8 (92.1 %) | 0.870b |
| R1/2 | 29 (3.9 %) | 8 (9.5 %) | 21 (3.2 %) | 2.32 (0.81–6.09) | 7 (8.4 %) | 49.2 (7.9 %) | ||||
| UICC Stage | I | 166 (22.2 %) | 13 (15.5 %) | 153 (23.1 %) | 0.332b | Reference | 0.599 | 13 (15.7 %) | 69.9 (11.3 %) | 0.698b |
| II | 212 (28.4 %) | 23 (27.4 %) | 189 (28.5 %) | 1.41 (0.63–3.29) | 23 (27.7 %) | 172.4 (27.8 %) | ||||
| III | 220 (29.5 %) | 27 (32.1 %) | 193 (29.1 %) | 1.30 (0.55–3.15) | 26 (31.3 %) | 209.8 (33.8 %) | ||||
| IV | 149 (19.9 %) | 21 (25.0 %) | 128 (19.3 %) | 1.83 (0.72–4.71) | 21 (25.3 %) | 168.9 (27.2 %) | ||||
| Tumor diameter | mm | 45.8 ± 21.6 | 45.7 ± 20.6 | 45.8 ± 21.7 | 0.831a | 0.99 (0.98–1.00) | 0.107 | 45.6 ± 20.7 | 43.7 ± 19.3 | 0.421a |
| Lymph node yield | <12 | 166 (22.2 %) | 10 (11.9 %) | 156 (23.5 %) | 0.016b | Reference | 0.040 | 10 (12.0 %) | 46.1 (7.4 %) | 0.143b |
| 12+ | 581 (77.8 %) | 74 (88.1 %) | 507 (76.5 %) | 2.08 (1.03–4.58) | 73 (88.0 %) | 574.9 (92.6 %) | ||||
| Tumor grading | G1 | 23 (3.1 %) | 3 (3.6 %) | 20 (3.0 %) | 0.180b | Reference | 0.196 | 3 (3.6 %) | 29.2 (4.7 %) | 0.823b |
| G2 | 540 (72.3 %) | 53 (63.1 %) | 487 (73.5 %) | 0.45 (0.14–2.03) | 52 (62.7 %) | 355.9 (57.3 %) | ||||
| G3 | 148 (19.8 %) | 21 (25.0 %) | 127 (19.2 %) | 0.62 (0.17–2.99) | 21 (25.3 %) | 175.1 (28.2 %) | ||||
| GX | 36 (4.8 %) | 7 (8.3 %) | 29 (4.4 %) | 1.21 (0.26–6.73) | 7 (8.4 %) | 60.7 (9.8 %) | ||||
| Adjuvant Chemotherapy | No | 505 (67.6 %) | 51 (60.7 %) | 454 (68.5 %) | 0.152b | Reference | 0.785 | 51 (61.4 %) | 382.8 (61.6 %) | 0.973b |
| Yes | 242 (32.4 %) | 33 (39.3 %) | 209 (31.5 %) | 1.09 (0.59–2.01) | 32 (38.6 %) | 238.2 (38.4 %) | ||||
n (%); mean ± standard deviation
Number of patients after elective operation with decimals because of weigthing in the propensity score matching analysis
a Mann–Whitney U-test; b Chi-Square statistic; c Likelihood ratio test
Prognostic factors for overall and disease-free survival after colorectal cancer resection
| Prognostic factors | Overall survival | Disease free survival | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unadjusteda | Full modelb | Backwards variable selectionc | Unadjusteda | Full modelb | Backwards variable selectionc | ||||||||
| HR (95 % CI) |
| HR (95 % CI) |
| HR (95 % CI) |
| HR (95 % CI) |
| HR (95 % CI) |
| HR (95 % CI) |
| ||
| Cancer resection | Elective | Reference | 0.045 | Reference | 0.629 | – | – | Reference | 0.043 | Reference | 0.877 | – | – |
| Urgent | 1.35 (1.02–1.78) | 1.08 (0.79–1.48) | – | – | 1.33 (1.02–1.74) | 1.02 (0.76–1.38) | – | – | |||||
| Age | years | 1.04 (1.03–1.05) | <0.001 | 1.05 (1.04–1.06) | <0.001 | 1.05 (1.04–1.06) | <0.001 | 1.03 (1.03–1.04) | <0.001 | 1.04 (1.03–1.05) | <0.001 | 1.04 (1.03–1.05) | <0.001 |
| Sex | m | Reference | 0.973 | Reference | 0.850 | – | – | Reference | 0.478 | Reference | 0.381 | – | – |
| w | 1.00 (0.84–1.20) | 0.98 (0.81–1.19) | – | – | 0.94 (0.79–1.12) | 0.92 (0.76–1.11) | – | – | |||||
| Tumor localisation | Cecum | Reference | 0.004 | Reference | 0.002 | Reference | 0.003 | Reference | 0.018 | Reference | 0.026 | Reference | 0.031 |
| Asc. colon | 0.72 (0.53–0.96) | 0.60 (0.44–0.82) | 0.62 (0.46–0.83) | 0.76 (0.57–1.02) | 0.67 (0.49–0.91) | 0.68 (0.50–0.91) | |||||||
| Transv. colon | 0.81 (0.53–1.23) | 0.62 (0.40–0.97) | 0.63 (0.41–0.97) | 0.78 (0.51–1.18) | 0.62 (0.40–0.95) | 0.63 (0.41–0.96) | |||||||
| Desc. olon | 0.87 (0.62–1.22) | 0.90 (0.63–1.28) | 0.90 (0.64–1.27) | 0.94 (0.68–1.31) | 0.99 (0.70–1.39) | 1.03 (0.74–1.45) | |||||||
| Sigm. colon | 0.73 (0.56–0.95) | 0.66 (0.50–0.88) | 0.68 (0.51–0.89) | 0.80 (0.62–1.04) | 0.79 (0.60–1.05) | 0.83 (0.63–1.08) | |||||||
| Rectum | 0.56 (0.42–0.74) | 0.57 (0.42–0.79) | 0.58 (0.43–0.78) | 0.62 (0.47–0.81) | 0.70 (0.51–0.95) | 0.74 (0.56–0.99) | |||||||
| Perforation | No | Reference | 0.525 | Reference | 0.492 | – | – | Reference | 0.684 | Reference | 0.704 | – | – |
| Yes | 1.10 (0.82–1.49) | 1.13 (0.80–1.58) | – | – | 1.06 (0.79–1.42) | 1.07 (0.77–1.48) | – | – | |||||
| Protec. colostomy | No | Reference | 0.929 | Reference | 0.530 | – | – | Reference | 0.987 | Reference | 0.783 | – | – |
| Yes | 1.01 (0.77–1.33) | 1.10 (0.81–1.50) | – | – | 1.00 (0.77–1.31) | 1.04 (0.77–1.41) | – | – | |||||
| Resection status | R0 | Reference | <0.001 | Reference | 0.001 | Reference | <0.001 | Reference | <0.001 | Reference | 0.004 | Reference | 0.003 |
| R1/2 | 3.21 (2.16–4.75) | 2.22 (1.45–3.38) | 2.30 (1.52–3.49) | 3.07 (2.08–4.55) | 1.97 (1.29–3.02) | 1.97 (1.30–3.00) | |||||||
| UICC Stage | I | Reference | <0.001 | Reference | <0.001 | Reference | <0.001 | Reference | <0.001 | Reference | <0.001 | Reference | <0.001 |
| II | 1.28 (0.97–1.69) | 1.21 (0.89–1.64) | 1.25 (0.93–1.67) | 1.41 (1.08–1.85) | 1.39 (1.03–1.87) | 1.37 (1.03–1.82) | |||||||
| III | 1.67 (1.27–2.19) | 1.67 (1.22–2.29) | 1.74 (1.29–2.36) | 1.80 (1.38–2.34) | 1.79 (1.31–2.43) | 1.75 (1.30–2.36) | |||||||
| IV | 4.02 (3.02–5.35) | 4.89 (3.45–6.94) | 5.10 (3.64–7.14) | 4.83 (3.65–6.40) | 5.64 (3.99–7.97) | 5.58 (4.00–7.79) | |||||||
| Tumor diameter | mm | 1.00 (1.00–1.01) | 0.071 | 1.00 (1.00–1.01) | 0.730 | – | – | 1.00 (1.00–1.01) | 0.043 | 1.00 (1.00–1.01) | 0.829 | – | – |
| Lymph node yield | <12 | Reference | 0.662 | Reference | 0.006 | Reference | 0.007 | Reference | 0.662 | Reference | 0.173 | – | – |
| 12+ | 0.95 (0.77–1.18) | 0.72 (0.57–0.91) | 0.73 (0.58–0.91) | 1.05 (0.85–1.29) | 0.85 (0.68–1.07) | – | – | ||||||
| Tumor grading | G1 | Reference | 0.012 | Reference | 0.367 | – | – | Reference | 0.001 | Reference | 0.009 | Reference | 0.007 |
| G2 | 1.09 (0.65–1.82) | 1.23 (0.72–2.09) | – | – | 1.07 (0.65–1.77) | 1.21 (0.72–2.03) | 1.20 (0.72–2.00) | ||||||
| G3 | 1.58 (0.92–2.71) | 1.41 (0.80–2.47) | – | – | 1.66 (0.98–2.81) | 1.45 (0.84–2.50) | 1.42 (0.83–2.45) | ||||||
| GX | 1.33 (0.69–2.57) | 1.59 (0.81–3.14) | – | – | 1.57 (0.84–2.95) | 2.44 (1.27–4.68) | 2.49 (1.31–4.73) | ||||||
| Adjuvant chemo. | No | Reference | 0.679 | Reference | 0.042 | Reference | 0.027 | Reference | 0.501 | Reference | 0.142 | Reference | 0.142 |
| Yes | 0.96 (0.79–1.17) | 0.77 (0.60–0.99) | 0.76 (0.60–0.97) | 1.07 (0.88–1.29) | 0.84 (0.66–1.06) | 0.84 (0.66–1.06) | |||||||
HR Hazard ratios with 95 % confidence intervals (Wald type) and p-values of the likelihood ratio test
Prognostic factors for overall survival in:
*p values for likelihood ratio tes
aone Cox proportional hazards regression analyses for each factor
bCox proportional hazards regression analyses for all factors
cCox proportional hazards regression analyses for all factors after backwards variable selection
Fig. 1Kaplan–Meier curve for overall and disease-free survival in unadjusted analysis. The number of colorectal cancer patients at risk are given below each plot. Survival curves are provided with 95 % confidence intervals
Fig. 2Distribution of propensity scores before and after propensity score analysis. The left upper and lower panels show the distribution of the propensity scores for patients with urgent and elective operation before the matching procedure. The right upper and lower panels demonstrate the distribution of the propensity scores after bipartite propensity score matching
Fig. 3Kaplan–Meier curve for overall and disease-free survival in propensity score adjusted analysis. The number of colorectal cancer patients at risk are given below each plot. Survival curves are provided with 95 % confidence intervals